Similar immunogenetics of Barrett's oesophagus and cervical neoplasia: Is HPV the common denominator?

Journal of Clinical Pathology

Volumn 63, Issue 1, 2010, Pages 1-3

  Rajendra, S ^a   Robertson, I K ^b  

^a LAUNCESTON GENERAL HOSPITAL   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; CYCLIN D1; CYCLIN E; KI 67 ANTIGEN; PROTEIN P16; VIRUS DNA;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CHROMOSOMAL INSTABILITY; DISEASE ASSOCIATION; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOGENETICS; INTESTINE METAPLASIA; MALIGNANT TRANSFORMATION; METAPLASIA; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROLOGY; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 74049119495     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.067447     Document Type: Review

References (55)

1. IARC. Monographs on the evaluation of the carcinogenic risks to humans. Vol 90. Human papillomaviruses. Lyon: International Agency for Research on Cancer, 2007.
2. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
3. Walboomers J, Jacobs M, Manos M, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:1-3.
4. Castellsague X, Diaz M, de Sanjose S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst 2006;98:303-15.
5. Pirog EC, Kleter B, Olgac S, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.AmJ Pathol 2000;157:1055-62.
6. D'Souza G, Kreimer A, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56.
7. Syrjanen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002;55:721-8.
8. Odze R, Antonioli D, Shocket D, et al. Esophageal squamous papillomas. AmJ Surg Pathol 1993;17:803-12.
9. McKenna M, Brodsky L. Extraesophaeal acid reflux and recurrent respiratory papilloma in children. Int J Pediatr Otorhinolaryngol 2006;69:597-605.
10. Chandrasoma P. Controversies of the cardiacmucosa and Barrett's oesophagus. Histopathology 2005;46:361-73.
11. Paull A, Trier JS, Dalton MD, et al. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976;295:476-80.
12. Shields HM, Zwas F, Antonioli DA, et al. Detection by scanning electron microscopy of a distinctive esophageal surface cell at the junction of squamous and Barrett's epithelium. Dig Dis Sci 1993;38:97-108.
13. Nucci MR, Crum CP. Redefining early cervical neoplasia: recent progress. Adv Anat Pathol 2007;14:1-10.
14. Gaffikin L, LauterbachM, Blumenthal PD. Performance of visual inspection with acetic acid for cervical cancer screening: a qualitative summary of evidence to date. Obstet Gynecol Surv 2003;58:543-50.
15. Guelrud M, Herrera I. Acetic acid improves identification of remnant islands of Barrett's epithelium after endoscopic therapy. Gastrointest Endosc 1998;47:512-15.
16. Odze R, Antonioli D, Shocket D, et al. Esophageal squamous papillomas. AmJ Surg Pathol 1993;17:803-12.
17. Campo MS. Papillomas and cancer in cattle. Cancer Surv 1987;6:39-54.
18. Boland CR, Komarova NL, Goel A. Chromosomal instability and cancer: not just one CINgle mechanism. Gut 2009;58:163-4.
19. Tornesello ML, Monaco R, Nappi O, et al. Detection of mucosal and cutaneous human papillomaviruses in oesophagitis, squamous cell carcinoma and adenocarcinoma of the oesophagus. J Clin Virol 2009;45:28.
20. Acevedo-Nuno E, Gonzalez-Ojeda A, Vazquez-Camacho G, et al. Human papillomavirus DNA and protein in tissue samples of oesophageal cancer, Barrett's oesophagus and oesophagitis. Anticancer Res 2004;24:1319-24.
21. Rai N, Jenkins GJS, McAdam E, et al. Human papillomavirus infection in Barrett's oesophagus in the UK: an infrequent event. J Clin Virol 2008;43:250-2.
22. Lagergren J, Wang Z, Bergström R, et al. Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J Natl Cancer Inst 1999;91:156-62.
23. Kamangar F, You-Lin Qiao, Schiller JT, et al. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a highrisk region in China. Int J Cancer 2006;119:579-84.
24. Fearon ER, Volgelstein B. A genetic model of colorectal tumorigenesis. Cell 1990;61:759-67.
25. Jankowski JA, Wright NA, Meltzer SJ, et al. Molecular evolution of the metaplasia-dysplasiaadenocarcinoma sequence in the esophagus. Am J Pathol 1999;154:965-73.
26. Mitchell MF, Hittelman WN, Hong WK, et al. The natural history of cervical intraepithelial neoplasia: an argument for intermediate endpoint biomarkers. Cancer Epidemiol Biomarkers Prev 1994;3:619-26.
27. Witkiewicz AK, Hecht JL, Cviko A, et al. Microglandular hyperplasia: a model for the de novo emergence and evolution of endocervical reserve cells. Human Pathol 2005;36:154-61.
28. Park JJ, Sun D, Quade BJ, et al. Stratified mucinproducing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia? Am J Surg Pathol 2000;24:1414-19.
29. Kumar N, Bongiovanni M, Molliet MJ, et al. Diverse glandular pathologies coexist with high grade squamous intraepithelial lesion in cyto histological review of atypical glandular cells on ThinPrep specimens. Cytopathology 2008 Jun 3. [Epub ahead of print].
30. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;248:76-9.
31. Dyson N, Howley PM, Munger K, et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934-6.
32. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-91.
33. Cho NH, Kang S, Hong S, et al. Elevation of cyclin B1, active cdc2 and HuR in cervical neoplasia with human papillomavirus type 18 infection. Cancer Lett 2006;232:170-8.
34. Cheung TH, Yu MM, Lo KW, et al. Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix. Cancer Lett 2001;166:199-206.
35. Quade BJ, Park JJ, Crum CP, et al. In vivo cyclin E expression as a marker for early cervical neoplasia. Mod Pathol 1998;11:1238-46.
36. Polkowski W, van Lanschot JJ, ten kate FJ, et al. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. Surg Oncol 1995;4:163-71.
37. Feagins LA, Souza RF. Molecular biology of Barrett's esophagus. In: Sharma P, Sampliner R, eds. Barrett's esophagus and esophageal adenocarcinoma. 2nd edn. Malden, MA: Blackwell Publishing, 2006:82-91.
38. Arber N, Lightdale C, Rotterdam H, et al. Increased expression of the cyclin D1 gene in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 1996;5:457-9.
39. Sarbia M, Bektas N, Muller W, et al. Expression of cyclin E in dysplasia, carcinoma and non-malignant lesions of Barrett's esophagus. Cancer 1999;86:2597-601.
40. Geddert H, Heep HJ, Gabbert HE, et al. Expression of cyclin B1 in themetaplasia-dysplasia-carcinoma sequence of Barrett's esophagus. Cancer 2002;94:212-18.
41. Lu X, Feki A. Phenotypic features with p53 alterations related to human paillomavirus and prognostic evaluation in cervical cancer. Int J Gynecol Cancer 2006;16:708-17.
42. Tenti P, Pavanello S, Padovan L, et al. Analysis and clinical implications of p53 gene mutations and human paillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix. Am J Pathol 1998;152:1057-63.
43. Holowaty P, Miller AB, Rohan T, et al. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:252-8.
44. Reid BJ, Sanchez CA, Blount PL, et al. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 1993;105:119-29.
45. Schlecht NF, Platt RW, Duarte-Franco E, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 2003;17:1336-43.
46. Reid BJ, Levine DS, Longton G, et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 2000;95:1669-76.
47. Koshiol JE, Schroeder JC, Jamieson DJ, et al. Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer 2006;119:1623-9.
48. Davidson EJ, Davidson JA, Sterling JC, et al. Association between Human Leukocyte Antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women. Cancer Res 2003;63:400-3.
49. Rajendra S, Ackroyd R,Murad S, et al. HLA determinants of susceptibility to Barrett's oesophagus in Asians: a preliminary report. Aliment Pharmacol Ther 2005;21:1377-83.
50. Bontkes HJ, Walboomers JM, Meijer CJ, et al. Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression. Lancet 1998;351:187-8.
51. Montoya L, Saiz I, Rey G, et al. Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population. Eur J Immunogenet 1998;25:329-37.
52. Beskow AH, Josefsson AM, Gyllensten UB. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int J Cancer 2001;93:817-22.
53. Wank R, Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 1991;352:723-5.
54. Rajendra S, Mohan C, Ackroyd R. Personal View: Barrett's oesophagus, ulcerative colitis, sarcoidosis, Indian ethnicity and the HLA-7.1 ancestral haplotype: shared immunogenetics? www.GastroHep.com 2006 (accessed 20 Sep 2009).
55. Rajendra S, Ackroyd R, Karim N, et al. Loss of human leucocyte antigen class I and gain of class II expression are early events in carcinogenesis: clues from a study of Barrett's oesophagus. J Clin Pathol 2006;59:952-7.